clioquinol has been researched along with oxyquinoline in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (53.33) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 3 (10.00) | 29.6817 |
| 2010's | 8 (26.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Borchardt, RT; Mirth, DB; Sane, JN; Thakker, DR; Warner, VD | 1 |
| Buabut, B; Hongmanee, P; Palittapongarnpim, P; Rukseree, K; Somsri, B | 1 |
| Barlow, DJ; Benoni, G; Bompiani, KM; Caglič, D; Dickerson, TJ; Houseknecht, KL; Krutein, MC; Lairson, LL; Pelletier, JC; Reitz, AB; Smith, GR | 1 |
| Bush, AI; Fraser, BH; Greguric, I; Han, Y; Krause-Heuer, AM; Lewis, R; Liang, SH; Shoup, TM; Southon, AG; Vasdev, N; Volitakis, I; Zhang, B | 1 |
| Bernard, G; Griffith, RW | 1 |
| Hansson, O | 1 |
| Fischmeister, I; Hellgren, L; Vincent, J | 1 |
| Láng, B; Vitéz, I | 1 |
| Bass, TM; Chernomordik, AB; Mukhorskaia, VA; Ozerianskaia, NM; Rzhanova, VI | 1 |
| Neldner, KH | 1 |
| Smirnov, AN | 1 |
| Ivanova, SA; Paliĭ, GK | 1 |
| Butareva, TA; Kukushkin, AM; Nemkaeva, RM; Unzhakov, VP | 1 |
| Bass, TM | 1 |
| Basdevant, A; Guy-Grand, B; Raison, J; Sarragoussi, JJ; Soffer, M | 1 |
| Wojtowicz, EJ | 1 |
| Sturtevant, FM | 1 |
| Borg-Neczak, K; Tjälve, H | 1 |
| Ahmed, S; Belal, F; Ibrahim, F; Rizk, M; Sheribah, ZA | 1 |
| DUFOUR, A; INTEBI, D; KAMINSKY, A | 1 |
| Chen, D; Daniel, KG; Dou, QP; Yan, B | 1 |
| Cui, QC; Dou, QP; Sun, Y; Yan, B; Yang, L; Zhai, S | 1 |
| Choe, J; Han, S; Moon, H; Park, H | 1 |
| Baran, EJ; González-Baró, AC; Wagner, CC | 1 |
| Gobec, M; Gobec, S; Kljun, J; Mlinarič-Raščan, I; Sosič, I; Turel, I; Uršič, M | 1 |
| Andrisano, V; Bartolini, M; Bergamini, C; Bolognesi, ML; Fato, R; Korabecny, J; Prati, F; Soukup, O | 1 |
| Alves, RJ; Andrade, SF; Bergamo, VZ; Fuentefria, AM; Machado, GDRM; Pippi, B | 1 |
| Dolgova, NV; George, GN; Harris, HH; Kroll, T; Millhauser, GL; Pickering, IJ; Pushie, MJ; Roseman, G; Schilling, KM; Sokaras, D; Summers, KL | 1 |
| Almança, MAK; Andrade, SF; de Souza, LM; Ficagna, E; Fuentefria, AM; Gava, A; Joaquim, AR | 1 |
2 review(s) available for clioquinol and oxyquinoline
| Article | Year |
|---|---|
The halogenated 8-hydroxyquinolines.
Topics: Chlorquinaldol; Clioquinol; Halogens; Humans; Hydroxyquinolines; Iodoquinol; Oxyquinoline | 1977 |
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer.
Topics: Antineoplastic Agents; Apoptosis; Clioquinol; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Oxyquinoline; Protease Inhibitors; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2007 |
1 trial(s) available for clioquinol and oxyquinoline
| Article | Year |
|---|---|
[8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clioquinol; Female; Humans; Hydroxyquinolines; Male; Middle Aged; Onychomycosis; Oxyquinoline | 1986 |
27 other study(ies) available for clioquinol and oxyquinoline
| Article | Year |
|---|---|
Catechol O-methyltransferase. 8. Structure-activity relationships for inhibtion by 8-hydroxyquinolines.
Topics: Animals; Catechol O-Methyltransferase Inhibitors; Hydroxyquinolines; In Vitro Techniques; Liver; Male; Oxyquinoline; Rats; Regression Analysis; Structure-Activity Relationship | 1976 |
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Chloroquinolinols; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis, Pulmonary | 2007 |
Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.
Topics: Animals; Botulinum Toxins, Type A; Catalytic Domain; Humans; Hydrogen-Ion Concentration; Hydroxyquinolines; In Vitro Techniques; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Solubility; Structure-Activity Relationship | 2014 |
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease.
Topics: | 2015 |
Clioquinol.
Topics: Benzoates; Clioquinol; Drug Combinations; Drug Industry; Myelitis; Optic Neuritis; Oxyquinoline; Quinolines; Switzerland; Syndrome | 1977 |
Toxicity of oxyquinolines.
Topics: Clioquinol; Humans; Hydroxyquinolines; Myelitis; Optic Neuritis; Oxyquinoline; Syndrome | 1977 |
Infrared spectroscopy for tracing of topically applied ointment vehicles and active substances on healthy skin.
Topics: Balsams; Benzocaine; Clioquinol; Coal Tar; Cresols; Dermatologic Agents; Ethylenediamines; Humans; Lanolin; Neomycin; Oils; Ointment Bases; Oxyquinoline; Parabens; Petrolatum; Pharmaceutic Aids; Skin; Spectrophotometry, Infrared; Tars | 1975 |
Cholericidic effect of some intestinal disinfectants.
Topics: Animals; Cetrimonium Compounds; Cholera; Clioquinol; Drug Synergism; Guinea Pigs; Humans; Microbial Sensitivity Tests; Oxyquinoline; Oxytetracycline; Triclosan; Vibrio cholerae | 1975 |
[Development of drug resistance and the cross resistance in Shigella to certain chemotherapeutic preparations in vitro].
Topics: Clioquinol; Crossing Over, Genetic; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Furazolidone; In Vitro Techniques; Microbial Sensitivity Tests; Oxyquinoline; Shigella sonnei; Streptomycin; Ukraine | 1976 |
[Use of enteroseptal and its analogs].
Topics: Antidiarrheals; Benzoates; Bromelains; Clioquinol; Dehydrocholic Acid; Drug Combinations; Humans; Hydroxyquinolines; Nitro Compounds; Oxyphenonium; Oxyquinoline; Pancreatin; Phenanthrolines; Quinones | 1977 |
[Sensitivity of fungi in the genus Candida to antimicrobial preparations].
Topics: Amphotericin B; Antifungal Agents; Candicidin; Candida; Clioquinol; Colitis; Colitis, Ulcerative; Decamethonium Compounds; Drug Combinations; Drug Resistance, Microbial; Feces; Humans; Microbial Sensitivity Tests; Oxyquinoline; Quinaldines | 1986 |
More on S.M.O.N.
Topics: Clioquinol; Humans; Hydroxyquinolines; Optic Neuritis; Oxyquinoline; Spinal Cord Diseases | 1971 |
[Occurrence of cultures with episomal resistance to antibiotics among shigellae isolated in Kiev].
Topics: Ampicillin; Chloramphenicol; Clioquinol; Erythromycin Ethylsuccinate; Escherichia coli; Furazolidone; Humans; Kanamycin; Nalidixic Acid; Neomycin; Nitro Compounds; Nitrofurans; Nitrofurazone; Oxyquinoline; Penicillin Resistance; Plasmids; Polymyxins; Recombination, Genetic; Rifampin; Shigella flexneri; Shigella sonnei; Streptomycin; Tetracycline; Ukraine | 1974 |
Oxyquinoline toxicity.
Topics: Clioquinol; Diverticulum; Drug Combinations; France; Humans; Hydroxyquinolines; Male; Middle Aged; Myelitis; Optic Neuritis; Oxyquinoline; Syndrome | 1983 |
Reverse-phase high-performance liquid chromatographic determination of halogenated 8-hydroxyquinoline compounds in pharmaceuticals and bulk drugs.
Topics: Chloroquinolinols; Chromatography, High Pressure Liquid; Clioquinol; Hydroxyquinolines; Iodoquinol; Oxyquinoline | 1984 |
Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
Topics: Acrodermatitis; Clioquinol; Humans; Hydroxyquinolines; Myelitis; Optic Atrophy; Optic Neuritis; Oxyquinoline; Syndrome; Time Factors; Zinc | 1980 |
Effect of 8-hydroxy-, 8-mercapto- and 5-chloro-7-iodo-8-hydroxy-quinoline on the uptake and distribution of nickel in mice.
Topics: Administration, Oral; Animals; Brain; Clioquinol; Eye; Female; Mice; Mice, Inbred C57BL; Nickel; Oxyquinoline; Pancreas; Quinolines; Radioisotopes; Thyroid Gland; Tissue Distribution | 1994 |
LC of pharmaceutically important halogenated 8-hydroxyquinolines after precolumn derivatization with Pd (II).
Topics: Anti-Infective Agents, Local; Chromatography, High Pressure Liquid; Clioquinol; Dosage Forms; Halogens; Iodoquinol; Lead; Oxyquinoline; Palladium; Pharmaceutical Preparations | 2002 |
[The combination of 5-chloro-7-iodo-8-hydroxyquinoline and prednisolone. Its use in dermatology].
Topics: Clioquinol; Dermatology; Humans; Oxyquinoline; Prednisolone | 1962 |
Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells.
Topics: Antineoplastic Agents; Biological Transport; Cell Proliferation; Clioquinol; Copper; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Organometallic Compounds; Oxyquinoline; Protease Inhibitors; Proteasome Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured | 2010 |
Crystal structures of human FIH-1 in complex with quinol family inhibitors.
Topics: Cell Hypoxia; Clioquinol; Crystallization; Enzyme Inhibitors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ketoglutaric Acids; Mixed Function Oxygenases; Multiprotein Complexes; Oxyquinoline; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs; Repressor Proteins; Substrate Specificity | 2010 |
Vibrational spectra of the Ga(III) complexes with oxine and clioquinol.
Topics: Clioquinol; Gallium; Molecular Structure; Oxyquinoline; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Vibration | 2011 |
Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Clioquinol; Copper; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukemia; MCF-7 Cells; NF-kappa B; Oxyquinoline; Proteasome Endopeptidase Complex; Ruthenium | 2014 |
Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Clioquinol; Copper; Donepezil; Drug Design; Human Umbilical Vein Endothelial Cells; Humans; Indans; Oxyquinoline; Piperidines; Structure-Activity Relationship; Zinc | 2016 |
Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices.
Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Clioquinol; Copper; Female; Humans; Intrauterine Devices; Microbial Sensitivity Tests; Oxyquinoline | 2018 |
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Chelating Agents; Clioquinol; Copper; Humans; Ions; Metals; Oxyquinoline; Peptide Fragments; Solvents; Zinc | 2022 |
In vitro evaluation of the efficacy of 8-hydroxyquinoline derivatives for the control of Phaeomoniella chlamydospora, the causative agent of Petri disease in grapevines.
Topics: Ascomycota; Clioquinol; Fungicides, Industrial; Humans; Oxyquinoline | 2023 |